| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 29 |
| 1 | METHOTREXATE | 25 |
| 2 | ADALIMUMAB | 21 |
| 3 | GABAPENTIN | 17 |
| 4 | PREDNISONE | 16 |
| 5 | ETANERCEPT | 14 |
| 6 | INTERFERON BETA-1A | 13 |
| 7 | ERGOCALCIFEROL | 12 |
| 8 | INFLIXIMAB | 12 |
| 9 | RANITIDINE | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PHENOXYBENZAMINE HYDROCHLORIDE | 1 | 0.0370 |
| 1 | NIPOCALIMAB-AAHU | 1 | 0.0031 |
| 2 | PENICILLIN G SODIUM | 2 | 0.0017 |
| 3 | DACTINOMYCIN | 3 | 0.0014 |
| 4 | OMEPRAZOLE, SODIUM BICARBONATE | 1 | 0.0010 |
| 5 | MARAVIROC | 2 | 0.0009 |
| 6 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 2 | 0.0007 |
| 7 | POTASSIUM ACETATE | 1 | 0.0007 |
| 8 | INFLIXIMAB-DYYB | 2 | 0.0006 |
| 9 | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 2 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 27 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 26 |
| 2 | Corticosteroid [EPC] | 25 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 25 |
| 4 | Vitamin C [EPC] | 15 |
| 5 | Benzodiazepine [EPC] | 13 |
| 6 | Interferon beta [EPC] | 13 |
| 7 | Dihydropyridine Calcium Channel Blocker [EPC] | 12 |
| 8 | Provitamin D2 Compound [EPC] | 12 |
| 9 | Estrogen [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Actinomycin [EPC] | 3 | 0.0014 |
| 2 | CCR5 Co-receptor Antagonist [EPC] | 2 | 0.0009 |
| 3 | Provitamin D2 Compound [EPC] | 12 | 0.0004 |
| 4 | Estrogen Agonist/Antagonist [EPC] | 1 | 0.0004 |
| 5 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 6 | Cardiac Myosin Inhibitor [EPC] | 1 | 0.0002 |
| 7 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |
| 8 | Thrombopoietin Receptor Agonist [EPC] | 2 | 0.0001 |
| 9 | Cannabinoid [EPC] | 1 | 0.0001 |